Abbott Laboratories leadership

Dr. Nita Ahuja has served as Dean of the University of Wisconsin School of Medicine and Public Health, Vice Chancellor of Medical Affairs, and Professor in the Department of Surgery since May 2025. She previously served as Chair of the Department of Surgery at Yale School of Medicine from 2018 to 2025 and Surgeon-in-Chief for Yale New Haven Health System from 2020 to 2025. She joined Abbott's Board of Directors in December 2025.

Dr. Robert J. Alpern serves as a director of Abbott Laboratories. He is not standing for re-election at the 2026 Annual Meeting and will continue to serve as a director until that meeting.

Claire Babineaux-Fontenot has served as Chief Executive Officer of Feeding America since October 2018 and has announced her retirement after a transition period in 2026. She previously served as Executive Vice President and Global Treasurer of Walmart Inc. from 2014 to 2017 and as Senior Vice President and Chief Tax Officer of Walmart from 2007 to 2014. She joined Abbott's Board of Directors in 2022.

Dr. Sally E. Blount has served as Chief Executive Officer of Catholic Charities of the Archdiocese of Chicago since 2020 and is the Michael L. Nemmers Professor of Strategy at Northwestern University's J.L. Kellogg Graduate School of Management. She served as Dean of the Kellogg School from 2010 to 2018. She joined Abbott's Board of Directors in 2011.

Robert B. Ford has served as Chairman of the Board and Chief Executive Officer of Abbott since December 2021, having been President and Chief Executive Officer from 2020 to 2021 and President and Chief Operating Officer from 2018 to 2020. He joined Abbott in 1996 and held various leadership roles across the Diagnostics, Nutrition, and Diabetes Care businesses. He was elected a corporate officer in 2008 and joined the Board in 2019.

Paola Gonzalez has served as Vice President, Global Financial Planning & Analysis of The Clorox Company since June 2023, and previously was Vice President and Treasurer of Clorox from 2018 to 2023. She joined Clorox in 1997 and held various finance leadership roles before that worked in finance for American Airlines in Latin America. She joined Abbott's Board of Directors in 2021.

Michelle A. Kumbier has served as Senior Vice President and President, Turf & Consumer Products of Briggs & Stratton, LLC since March 2022. She previously served as Senior Vice President and Chief Operating Officer of Harley-Davidson Motor Company from 2017 to 2020 and held various executive roles at Harley-Davidson from 1997 to 2015. She joined Abbott's Board of Directors in 2018.

General Darren W. McDew is a retired four-star general who served 36 years in the United States military before retiring in October 2018, including as Commander of U.S. Transportation Command from 2015 to 2018. He held various leadership roles across the U.S. military including Military Aide to the President and Director of Air Force Public Affairs. He joined Abbott's Board of Directors in 2019.

Nancy McKinstry served as Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. from September 2003 to February 2026 and was a member of its Executive Board from June 2001 to February 2026. She serves as Abbott's Lead Independent Director and joined the Board in 2011.

Michael G. O'Grady has served as Chairman of Northern Trust Corporation since 2019, Chief Executive Officer since 2018, and President since 2017. He previously served as Northern Trust's Chief Financial Officer from 2011 to 2014 and as a Managing Director in the Investment Banking Group of Bank of America Merrill Lynch from 2000 to 2011. He joined Abbott's Board of Directors in 2023.

Michael F. Roman served as Executive Chairman of the Board of 3M Company from May 2024 to March 2025 and as Chairman of the Board, President and Chief Executive Officer of 3M from 2019 to 2024. He held numerous leadership roles at 3M including Chief Operating Officer and Executive Vice President from 2017 to 2018. He joined Abbott's Board of Directors in 2021.

Daniel J. Starks served as Chairman, President and Chief Executive Officer of St. Jude Medical, Inc. from 2004 until his retirement in January 2016, and as Executive Chairman from January 2016 to January 2017 when Abbott completed its acquisition of St. Jude Medical. He joined St. Jude Medical in 1996. He joined Abbott's Board of Directors in 2017.

John G. Stratton served as Executive Chairman of Frontier Communications Parent, Inc. from April 2021 to January 2026 and previously as Executive Vice President and President of Global Operations of Verizon Communications Inc. from 2015 to 2018. He held various senior executive roles at Verizon including Chief Operating Officer of Verizon Wireless from 2010 to 2012. He joined Abbott's Board of Directors in 2017.

Kevin Conroy was named to the Abbott Laboratories Board of Directors on April 24, 2026. His appointment was reported in Abbott's Form 8-K filed April 27, 2026; no additional biographical information is provided in the source filings.

Philip P. Boudreau has served as Executive Vice President, Finance and Chief Financial Officer of Abbott since 2024, having been Senior Vice President, Finance and Chief Financial Officer from 2023 to 2024 and Vice President, Finance and Controller from 2020 to 2023. He joined Abbott in 1997 and was elected a corporate officer in 2020.

Elizabeth C. Cushman has served as Executive Vice President, General Counsel and Secretary of Abbott since 2025, having been Senior Vice President, Legal from 2024 to 2025 and Vice President, Specialty Legal from 2023 to 2024. She was elected a corporate officer in 2023.

Lisa D. Earnhardt has served as Executive Vice President and Group President, Medical Devices of Abbott since 2023, having been Executive Vice President, Medical Devices from 2019 to 2023. She was elected a corporate officer in 2019.

Mary K. Moreland has served as Executive Vice President, Human Resources of Abbott since 2019. She was elected a corporate officer in 2019.

Louis H. Morrone has served as Executive Vice President, Core Diagnostics of Abbott since 2023, having been Senior Vice President, Rapid Diagnostics from 2021 to 2023 and Vice President, Transfusion Medicine from 2017 to 2021. He was elected a corporate officer in 2017.

Daniel Salvadori has served as Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products of Abbott since 2021, having been Executive Vice President, Nutritional Products from 2017 to 2021. He was elected a corporate officer in 2014.

Christopher J. Scoggins has served as Executive Vice President, Diabetes Care of Abbott since 2025. He previously served as Senior Vice President, Commercial Operations and Marketing, Abbott Diabetes Care from 2023 to 2024, Vice President, Commercial Operations and Marketing from 2021 to 2023, and Senior Vice President, Rapid Diagnostics from 2019 to 2021. He was elected a corporate officer in 2015.

Eric Shroff has served as Senior Vice President, Rapid and Molecular Diagnostics of Abbott since 2025, having been Vice President, Abbott Point of Care from 2018 to 2025. He was elected a corporate officer in 2018.

John A. McCoy, Jr. has served as Vice President, Finance and Controller of Abbott since 2023, having been Vice President, Treasurer from 2021 to 2023 and Divisional Vice President, Controller, Rapid Diagnostics from 2018 to 2021. Prior to joining Abbott in 2017, he served as Senior Vice President and Corporate Controller at Baxalta Incorporated from 2015 to 2017; he was elected a corporate officer in 2021.